Joseph Surber

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Mark H. Wilcox, G. Ralph Corey, George H. Talbot et al. · Journal of Antimicrobial Chemotherapy · 2010 · 215 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections

Philippe Prokocimer, Paul Bien, Joseph Surber et al. · Antimicrobial Agents and Chemotherapy · 2010 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 64 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Teresa H. Evering, Mark J Giganti, Carlee Moser et al. · Annals of Internal Medicine · 2023 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17